Faculty Opinions recommendation of Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.

2013 ◽  
Author(s):  
David Kushner ◽  
Ryan Spencer
Keyword(s):  
Endometrial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Oncology Group ◽  
Oncology Group Study

Phase II Trial of Pyrazoloacridine in Patients with Persistent or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study

2002 ◽  
Vol 84 (2) ◽  
pp. 241-244 ◽  
Author(s):  
Steven C. Plaxe ◽  
John A. Blessing ◽  
Nader Husseinzadeh ◽  
Kenneth D. Webster ◽  
Janet S. Rader ◽  
...  
Keyword(s):  
Endometrial Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Gynecologic Oncology ◽  
Gynecologic Oncology Group ◽  
Oncology Group ◽  
Oncology Group Study
Sign in / Sign up

Export Citation Format

Share Document